Simulations Plus, Inc.

NASDAQ:SLP

Medical - Healthcare Information Services

Healthcare
$18.50 +0.11%

+$0.02 today

Market cap
$374.16M
Beta
1.32
P/E (TTM)
-5.9
EPS (TTM)
-$3.12
52W Low $11.09High $21.01

Volume 0.00M

Average 0.35M

SLP Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Simulations Plus, Inc.NASDAQ: SLP

Accounts Payables · Q2 FY2026 · quarter ended Feb 2026

Accounts payables turns negative

Q2 FY2026 accounts payables was -$60K, compared with $86K a year earlier. Trailing-twelve-month accounts payables was -$403K. Over 3 fiscal years it compounded at -6.6% a year.

Context

  • Accounts payables amounted to 0.2% of revenue in FY2025, down 0.5 pp from a year earlier.
  • Accounts payables grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly accounts payables holds near -$60K or moves back toward the trailing-twelve-month quarterly average of -$100.75K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterFeb 2026
-$60K-115.3% QoQ
Last fiscal yearAug 2025
-$132K-72.3% YoY
LTMFeb 2026
-$403K+352.8% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-169.8%——
1 year-72.3%——
3-year CAGR-6.6%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
(132K) USD
Year-over-year change
+72.3%

Accounts Payables vs competitors

How SLP compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +352.8% is the 2nd highest of 9, against a peer median of -31.0%.
  • Accounts payables amounts to 0.5% of revenue for SLP, versus a peer median of 2.5%.
SLP Competitors
Accounts Payables for SLP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$12.45M USD+595.4%—15.3%
NAKANakamoto Inc.LTM Mar 2026$8.24M USD-11230.1%—210.1%
DHDefinitive Healthcare Corp.LTM Mar 2026$3.92M USD-34.4%—1.6%
OPRXOptimizeRx CorporationLTM Mar 2026$2.71M USD+69.8%—2.5%
KRROKorro Bio, Inc.LTM Mar 2026$2.56M USD-290.8%—66.7%
ANROAlto Neuroscience, Inc.LTM Mar 2026$1.98M USD+327.2%-39.7%—
CLLSCellectis S.A.LTM Mar 2026$1.34M USD-181.1%—2.0%
NRCNational Research CorporationLTM Mar 2026$485K USD-27.6%—0.3%
SLPSimulations Plus, Inc.LTM Feb 2026$403K USD+352.8%-6.6%0.5%
ACIUAC Immune S.A.LTM Dec 2025CHF 327.34K CHF——9.2%
AGLAgilon Health, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding SLP) —-31.0%-39.7%2.5%

Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Aug 2023
FY2024
Aug 2024
FY2025
Aug 2025
Net Income9.78M12.48M9.96M9.95M(64.72M)
Depreciation & Amortization3.59M3.57M3.84M5.67M8.21M
Deferred Income Tax(628K)(270K)(2.1M)(1.77M)(5.43M)
Stock-Based Compensation2.75M3.04M4.83M6.54M6.35M
Change in Working Capital974K(2.62M)5.1M(4.21M)(2.59M)
Accounts Receivables(2.43M)(3.94M)4.1M3.13M(581K)
Inventory3.15M0000
Accounts Payables39K(162K)(81K)(477K)(132K)
Other Working Capital210K1.48M1.09M(6.86M)(1.87M)
Other Non-Cash Items2.74M1.7M219K(2.86M)76.29M
Operating Cash Flow19.2M17.9M21.86M13.32M18.13M
Capital Expenditures(4.58M)(3.97M)(4.27M)(566K)(713K)
Acquisitions (Net)2.95M3.15M(8.22M)(98.77M)0
Purchases of Investments(122.4M)(100.85M)(95.05M)(67.16M)(6.5M)
Sales of Investments100.23M109.12M114.91M116.27M15.01M
Other Investing Activities(2.95M)(3.15M)(3.82M)(3.74M)(4.24M)
Investing Cash Flow(26.74M)4.31M7.37M(53.97M)3.56M
Debt Repayment00000
Common Stock Issued1.46M891K0731K430K
Common Stock Repurchased00(20M)00
Dividends Paid(4.81M)(4.85M)(4.81M)(4.8M)0
Other Financing Activities(1.33M)(3.67M)1.54M(2.5M)(1.58M)
Financing Cash Flow(4.68M)(7.62M)(23.27M)(6.57M)(1.15M)
Effect of Forex Changes00000
Net Change in Cash(12.22M)14.58M5.96M(47.21M)20.54M
Free Cash Flow14.63M13.93M17.58M12.75M17.41M

Simulations Plus, Inc.

NASDAQ:SLP

Intrinsic Alpha fair value

Locked

Current Price

$18.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.